Bioethics

  • Home
  • About
  • Events
  • Bioethics Resources
    • Featured Articles
    • Academic Programs & Certificates
    • Bioethics Centers & Institutions
    • Bioethics Journals & Publications
    • Multimedia Resources
    • Bioethics 101 Resources
    • Book Reviews
    • Movie Reviews
    • Employment, Fellowships & Internships
  • Topics

Your global information source on bioethics news, issues, & events

  • Twitter
  • RSS
  • Artificial Intelligence
  • Biotech
  • Clinical / Medical
  • Cloning
  • Covid-19
  • Culture
  • Disability Ethics
  • Disaster Ethics
  • Education
  • Emerging Technologies
  • Employment / Fellowships / Internships
  • End of Life
  • Eugenics
  • Euthanasia / Suicide
  • Genetic Ethics
  • Geriatric & Aging
  • Global Bioethics
  • Healthcare
  • Human Dignity
  • Human Enhancement
  • Informed Consent
  • Journal Articles
  • Medical Tourism
  • Mental Health
  • Multimedia Resources
  • Nanotechnology
  • Neuroethics
  • Nursing
  • Organ Donation / Transplantation
  • Pediatric
  • Pharma
  • Public Health
  • Public Policy
  • Reproductive Ethics
  • Research Ethics
  • Reviews
  • Stem Cell Research
  • Synthetic Biology
  • Women's Health
Pharma

Pharma

August 1, 2025

An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors

(NPR) – Nearly one in five pregnant women and new moms in this country suffers from anxiety and depression. And 6-8% of pregnant women are prescribed a group of antidepressants called Selective Serotonin Reuptake Inhibitors (SSRIs). But a recent expert … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, Mental Health, News, Pharma, Reproductive Ethics



 
 

August 1, 2025

A New Edition of The New England Journal of Medicine Is Now Available

The New England Journal of Medicine (vol. 393, no. 1, 2025) is available online by subscription only. Articles include:

Posted by Bioethcs Research Assistant

Posted in Clinical / Medical, Healthcare, Journal Articles, Pharma, Public Health



 
 

July 31, 2025

‘Ozempic face’ may be driving a cosmetic surgery boom

(CNN) – About two years ago, celebrity cosmetic dermatologist Dr. Paul Jarrod Frank noticed a new type of patient arriving at his New York practice. Amid an explosion in the number of Americans losing weight with drugs like Ozempic, he … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pharma



 
 

July 31, 2025

Without Federal Funding, Antibiotics Research May Lag

(Undark) – In May, U.S. officials terminated all NIH applications for grants with foreign subawards — the type of grant that applies to Wright’s work. The agency previously approved some 3,600 grants that awarded about $400 million to support researchers … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma, Public Policy, Research Ethics



 
 

July 30, 2025

Stronger Than Fentanyl: A Drug You’ve Never Heard of Is Killing Hundreds Every Year

(Wall Street Journal) – Ultrapotent nitazenes, mostly from China, are easy to smuggle and mix into heroin, recreational drugs and gray-market pharmaceuticals Fentanyl fueled the worst drug crisis the West has ever seen. Now, an even more dangerous drug is … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, highlights, Mental Health, Neuroethics, News, Pharma, Public Health



 
 

July 29, 2025

Morton Mintz, Post reporter with a muckraker spirit, dies at 103

(Washington Post) – A pioneer in consumer affairs journalism, he helped expose the deformity-causing hazards posed by thalidomide, a once-popular drug for morning sickness. Morton Mintz, a Washington Post reporter who brought a muckraker’s zeal to business reporting, notably by … Read More

Posted by Bioethics Pundit

Posted in General Bioethics, Informed Consent, News, People, Pharma



 
 

July 28, 2025

Man sues over girlfriend’s abortion in a first-of-its-kind lawsuit

(Washington Post) – The first-of-its-kind wrongful-death lawsuit tests the laws blue states passed to protect abortion access after the Supreme Court overturned Roe v. Wade. A Texas man whose girlfriend used abortion pills to end her pregnancy is suing a … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, News, Pharma, Public Policy, Reproductive Ethics



 
 

July 28, 2025

Why GLP-1s could become the “everything drug”

(Axios) – The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for patients and insurers. The big picture: Blockbuster treatments like Ozempic have been found to lower … Read More

Posted by Bioethics Pundit

Posted in highlights, Informed Consent, News, Pharma



 
 

July 25, 2025

Weak regulation causing deaths due to contaminated medicines, WHO says

(Reuters) – The World Health Organization said on Thursday systemic weaknesses in the oversight of the global pharmaceutical supply chain have resulted in medicines formulated with poisonous chemicals claiming lives and compromising the health of patients, mainly children. In a … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, highlights, News, Pediatric, Pharma



 
 

July 25, 2025

EU regulator green lights an injectable HIV drug that could help stop transmission

(ABC News) – The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement on Friday, the EU drug regulator said its evaluations of … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, News, Pharma



 
 

July 22, 2025

First Hormone-Free Male Birth Control Pill Shown Safe in Early Human Trial

(Scientific American) – A hormone-free pill, called YCT-529, that temporarily stops sperm production by blocking a vitamin A metabolite has just concluded its first safety trial in humans, getting a step closer to increasing male contraceptive options When it comes … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, News, Pharma, Reproductive Ethics



 
 

July 22, 2025

First Pill for Postpartum Depression Shows Varied Real-World Results

(New York Times) – Clinical trials had found that the drug, zuranolone, marketed as Zurzuvae and taken daily for 14 days, can ease symptoms for some women in as little as three days, while general antidepressants can take weeks. For … Read More

Posted by Bioethics Pundit

Posted in highlights, Mental Health, News, Pharma, Reproductive Ethics, Women's Health



 
 

July 21, 2025

Drugmaker refuses FDA request to pull gene therapy

(Axios) – An unusual public feud between the Food and Drug Administration and a maker of gene therapies for rare diseases could test the Trump administration’s willingness to pull certain approved drugs from the market over safety concerns. The big … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Genetic Ethics, highlights, Informed Consent, News, Pharma



 
 

July 18, 2025

This Simple Strategy Could Curb One of Semaglutide’s Worst Side Effects

(Gizmodo) – Semaglutide’s ability to help people lose weight is legendary, but so are the side effects. The active ingredient in medications Wegovy and Ozempic, semaglutide is renowned for causing severe nausea in some people, sometimes to the extent that … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Informed Consent, News, Pharma



 
 

July 15, 2025

Weight-loss drug use in kids surged after doctors’ recommendation

(Axios) – Use of GLP-1 drugs for weight loss rose sharply in kids and adolescents after the American Academy of Pediatrics in 2023 recommended offering medications along with lifestyle adjustments such as healthier eating and exercise. Why it matters: The … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Informed Consent, News, Pediatric, Pharma



 
 

July 11, 2025

F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs

(New York Times) – The Food and Drug Administration on Thursday published a database containing more than 200 letters to pharmaceutical companies detailing why the agency initially refused to approve their products, shedding light on an obscure and contentious aspect … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, News, Pharma



 
 

July 11, 2025

Fungal infections are getting harder to treat

(NBC News) – The fungus Aspergillus fumigatus tops the World Health Organization’s list of worrying fungal diseases. It’s growing increasingly resistant to the first-line drug used to treat it. Fungal infections are getting harder to treat as they grow more … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, highlights, News, Pharma, Public Health



 
 

July 10, 2025

What’s the Difference Between Hearing Aids and Puberty Blockers?

(The New Atlantis) – “We aren’t defective, just different” was the 1990s rallying cry of deaf activists who rejected medical fixes. Why have transgender activists argued that only medical tech can make them who they really are? As it happens, … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Disability Ethics, highlights, News, Pharma



 
 

July 9, 2025

Use of antibiotic to reduce STIs appears to be fueling some antibiotic resistance, research shows

(STAT News) – When several countries endorsed the notion of some high-risk people taking the antibiotic doxycycline after unprotected sex to lower their chances of contracting a sexually transmitted disease, as the U.S. did last year, there was a theoretical … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, News, Pharma



 
 

July 9, 2025

First malaria treatment for newborn babies approved for use

(Washington Post) – Malaria caused 597,000 deaths worldwide in 2023, with children under 5 accounting for 76 percent of all malaria deaths in the World Health Organization’s Africa region. The first malaria drug for newborn babies and those weighing less … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Global Bioethics, highlights, News, Pediatric, Pharma



 
 

July 8, 2025

Even low doses of CBD may cause harm to the liver in some people, FDA study finds

(NBC News) – There’s been little evidence on how well CBD works or guidance on how to safely use capsules, edibles or oils that contain cannabidiol. Over the course of four weeks, 201 volunteers received either 5 mg per kilogram … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, highlights, Informed Consent, News, Pharma



 
 

July 8, 2025

First malaria treatment for babies approved for use

(BBC) – The first malaria treatment suitable for babies and very young children has been approved for use. It’s expected to be rolled out in African countries within weeks. Until now there have been no approved malaria drugs specifically for … Read More

Posted by Bioethics Pundit

Posted in Global Bioethics, highlights, News, Pediatric, Pharma, Public Health



 
 

July 4, 2025

More measles outbreaks put US total within single digits of modern-day record

(CIDRAP) – In its weekly update today, the US Centers for Disease Control and Prevention (CDC) reported 40 more measles cases today, boosting the number of infections this year to 1,267, which is just 8 shy of passing the total … Read More

Posted by Bioethics Pundit

Posted in highlights, News, Pharma, Public Health



 
 

July 2, 2025

Top F.D.A. Official Overrode Scientists on Covid Shots

(New York Times) – The Food and Drug Administration’s top vaccine official rejected broad uses of two Covid vaccines, citing unknown risks or injuries despite assurances of safety from dozens of staff experts, newly released documents show. The decisions by … Read More

Posted by Bioethics Pundit

Posted in Clinical / Medical, Covid-19, highlights, Informed Consent, News, Pharma, Public Health



 
 

July 2, 2025

Some ADHD Meds Can Cause Significant Weight Loss in Young Kids, FDA Warns

(MedPage Today) – A new warning will be added to the label of certain attention deficit-hyperactivity disorder (ADHD) medications over the risk of “significant” weight-loss in young children, the FDA said. Labels of all extended-release stimulants indicated for ADHD — … Read More

Posted by Bioethics Pundit

Posted in Informed Consent, News, Pediatric, Pharma



 
 
Older posts Newer posts
  • Recent News
  • Trending
  • 10/30/2026Silicon Valley Is Grappling With a Flood of Bugs Found by A.I.
  • 10/30/2026“No human at the helm”: Delaware plan would let AI agents run entire businesses
  • 10/30/2026Anthropic Says It Will Revolutionize Biology—Some Day
  • 10/30/2026Doctor performs surgery on patient at hospital 35 miles away using robotics
  • 10/30/2026Are you an organ donor? Here are some rule changes you may want to know
More News
    • Artificial Intelligence
    • Biotech
    • Clinical / Medical
    • Cloning
    • Covid-19
    • Culture
    • Disability Ethics
    • Disaster Ethics
    • Education
    • Emerging Technologies
    • Employment / Fellowships / Internships
    • End of Life
    • Eugenics
    • Euthanasia / Suicide
    • Genetic Ethics
    • Geriatric & Aging
    • Global Bioethics
    • Healthcare
    • Human Dignity
    • Human Enhancement
      • Transhumanism
    • Informed Consent
    • Journal Articles
    • Medical Tourism
    • Mental Health
    • Multimedia Resources
    • Nanotechnology
    • Neuroethics
    • News
      • Op-Ed
    • Nursing
    • Organ Donation / Transplantation
    • Pediatric
    • Pharma
    • Public Health
    • Public Policy
    • Reproductive Ethics
    • Research Ethics
    • Reviews
      • Books
      • Movies
    • Stem Cell Research
    • Synthetic Biology
    • Women's Health
    Ad
    bioethics.com
    • Home
    • About
    • Events
    • Contact
    • Advertising

    bioethics.com © 2002–Present by CBHD is licensed under CC BY-NC-ND 4.0

    • Twitter
    • RSS

    A Project Of The Center for Bioethics & Human Dignity